Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

999 public trials 299 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Recruiting

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

NCT07041606

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Research Site Arkhangelsk, Russia
  • Research Site Barnaul, Russia
  • Research Site Chelyabinsk, Russia
  • Research Site Irkutsk, Russia
View all 19 locations
View Trial Details
Recruiting

Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

NCT04774419

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activites) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

NCT05950464

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
View all 14 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

NCT05579366

Conditions
Adenoma, Adnexal Diseases, Breast Adenocarcinoma, +49 more
Locations
  • USOR HonorHealth Phoenix, Arizona, United States
  • USOR Arizona Oncology Associates Tucson, Arizona, United States
  • University of California Los Angeles Medical Center Los Angeles, California, United States
  • University of California, San Diego; Moores Cancer Center San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

NCT07166094

Conditions
Disease Attributes, Endometrial Cancer, Endometrial Neoplasms, +15 more
Locations
  • HonorHealth Research Inst Phoenix, Arizona, United States
  • Kaiser Permanente SoCal Irvine, California, United States
  • MedStar Washington Hospital Washington D.C., District of Columbia, United States
  • SMH - Sarasota - Main Campus Sarasota, Florida, United States
View all 120 locations
View Trial Details

Related conditions